News

Minimally Invasive Biopsy Technologies Market Share, Forecast, Overview and Key Companies Analysis by 2028

September 1, 2021

The Global Minimally Invasive Biopsy Technologies Market is projected to reach USD 3.98 billion in 2027. The market is expected to be driven due to a higher proliferation of the minimally invasive surgical procedures in biopsy testing and an extensive rise in the rate of breast and lung cancers globally. Around 66% of the total initial breast biopsies performed in North America are minimally invasive breast biopsies (MIBB).

The report provides detailed insights into Minimally Invasive Biopsy Technologies market trends, industry trends, consumer trends, market size, market share, market revenue growth, and forecast, along with ranging impact of each factor and driver. It also provides analysis of various factors expected to restrain or limit potential growth in market size over the forecast period, 2020–2028. The report includes profiles of major players in the Minimally Invasive Biopsy Technologies market, strategies being employed, mergers, acquisitions, recent developments, agreements, contracts, new product development and launches, segment revenue, investment details as well as financials.

Download FREE Sample PDF Copy (Customized Sample PDF File delivered as per your specific requirement)@ https://www.emergenresearch.com/request-sample/75

The steady Minimally Invasive Biopsy Technologies market share growth can be attributed to a variety of factors and trends in the global Minimally Invasive Biopsy Technologies market currently. Global Minimally Invasive Biopsy Technologies market revenue growth is supported to a significant extent due to rising focus by major players on product/service expansion into new and untapped domestic markets and rising competition in the market. These factors are expected to drive incline in regional Minimally Invasive Biopsy Technologies market share growth over the forecast period.

In addition, rapidly rising demand and deployment in respective sectors/industries in major and developing countries is supporting growth in terms of Minimally Invasive Biopsy Technologies market share contribution of these countries. In addition, Minimally Invasive Biopsy Technologies market share contribution is expected to continue to incline steadily over the forecast period due to favorable government policies, advancements in technology, and steady economic growth across various regions and countries.

Top key vendors in Minimally Invasive Biopsy Technologies Market include are:

Key players in the market include Chronix Biomedical, Biocept, Inc., F. Hoffmann-La Roche Ltd, Mauna Kea Technologies, Veracyte, Inc., Thermo Fisher Scientific, NeoGenomics Laboratories, Inc., Abcodia Ltd., Adaptive Biotechnologies, and Owlstone Medical Ltd., among others.

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

For the purpose of this report, Emergen Research has segmented into the global Minimally Invasive Biopsy Technologies Market on the basis of Technology, Therapeutic Application, End-Use Verticals, and region:

Technology Outlook (Revenue: USD Billion; 2017-2027)
- Liquid Biopsy
- Optical Biopsy
- Brush Biopsy
- Pigmented Lesion Assays
- Breath Biopsy
- Brush Biopsy
- Others

Therapeutic Application Outlook (Revenue: USD Billion; 2017-2027)
- Lung Cancer
- Breast Cancer
- Prostate Cancer
- Colorectal Cancer
- Blood Cancer
- Non-oncology Applications

End-Use Verticals Outlook (Revenue: USD Billion; 2017-2027)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Cancer Research Institutes
- Others

Access the Entire Report packed with TOC, Tables and Figures and Outline of Prominent Companies@ https://www.emergenresearch.com/industry-report/minimally-invasive-biopsy-technologies-market

In terms of Minimally Invasive Biopsy Technologies market share and revenue contribution to the global Minimally Invasive Biopsy Technologies market, North America is expected to maintain its dominance over other regional markets over the forecast period. Presence of major companies in countries in the region is a key factor supporting rapid increase in Minimally Invasive Biopsy Technologies market share.

Incorporated with Info-graphics, charts, 70 tables and 85 figures, this 250-page research report “Minimally Invasive Biopsy Technologies Market Size, Type, Application, End-Use Industry, Regional Outlook, Competitive Strategies and Forecasts, 2020 – 2027” is based on a complete research of the entire Global market and covering all its sub-segments through comprehensively thorough classifications. Insightful analysis and assessment are created from superior primary and secondary information sources with data and information derived from industry specialists across the value chain.

Region wise performance of the Minimally Invasive Biopsy Technologies industry

Asia Pacific market share contribution to the global Minimally Invasive Biopsy Technologies market is expected to continue to register comparatively faster growth rate than other regional markets between 2020 and 2028. Rapid growth rate of China and India Minimally Invasive Biopsy Technologies market share contribution can be attributed to increasing population and disposable income, and steady economic growth, and the trend is expected to continue going ahead.

Steady increase in Europe Minimally Invasive Biopsy Technologies market share growth is primarily supported by continuous developments in major countries in the region. Robust focus on research and development initiatives by major firms in countries in the region is also expected to continue to support market share growth of the Europe Minimally Invasive Biopsy Technologies market going ahead.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering:

United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:

North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

We can customize our reports for our customers, for instance, we can add or remove manufacturers, applications or product types, whatever you need in the report. Ask for it by contacting us@ https://www.emergenresearch.com/request-for-customization/75

The research provides answers to the following key questions:

What will be the growth rate and the market size of the Minimally Invasive Biopsy Technologies industry for the forecast period 2020-2027?
What are the major driving forces expected to impact the development of the Minimally Invasive Biopsy Technologies market across different regions?
Who are the major driving forces expected to decide the fate of the Minimally Invasive Biopsy Technologies industry worldwide?
Who are the prominent market players making a mark in the Minimally Invasive Biopsy Technologies market with their winning strategies?
Which Minimally Invasive Biopsy Technologies industry trends are likely to shape the future of the industry during the forecast period 2020-2027?
What are the key barriers and threats believed to hinder the development of the industry?
What are the future opportunities in the Minimally Invasive Biopsy Technologies market?

Table of Content

Chapter 1. Methodology & Sources

1.1. Minimally Invasive Biopsy Technologies Market Definition

1.2. Research Scope

1.3. Methodology

1.4. Research Sources

1.4.1. Primary

1.4.2. Secondary

1.4.3. Paid Sources

1.5. Minimally Invasive Biopsy Technologies Market Estimation Technique

Chapter 2. Executive Summary

2.1. Summary Snapshot, 2024-2028